Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life

We examined the effectiveness of maternal vaccination against SARS-CoV-2 infection in 30,311 infants born at Kaiser Permanente Northern California from December 15, 2020, to May 31, 2022. Using Cox regression, the effectiveness of ≥2 doses of COVID-19 vaccine received during pregnancy was 84% (95% c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerbo, Ousseny, Ray, G. Thomas, Fireman, Bruce, Layefsky, Evan, Goddard, Kristin, Lewis, Edwin, Ross, Pat, Omer, Saad, Greenberg, Mara, Klein, Nicola P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974935/
https://www.ncbi.nlm.nih.gov/pubmed/36854660
http://dx.doi.org/10.1038/s41467-023-36547-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974935/
https://www.ncbi.nlm.nih.gov/pubmed/36854660
http://dx.doi.org/10.1038/s41467-023-36547-4

Ejemplares similares